Edition:
India

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

3.10CAD
10:28pm IST
Change (% chg)

$-0.03 (-0.96%)
Prev Close
$3.13
Open
$3.12
Day's High
$3.13
Day's Low
$3.07
Volume
6,544
Avg. Vol
88,802
52-wk High
$4.31
52-wk Low
$1.11

Chart for

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 3.51
Market Cap(Mil.): $206.99
Shares Outstanding(Mil.): 114.62
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates